A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
Titel:
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
Auteur:
Herschorn, Sender Barkin, Jack Castro-Diaz, David Frankel, Jeffrey M. Espuna-Pons, Montserrat Gousse, Angelo E. Stölzel, Matthias Martin, Nancy Gunther, Adrie Van Kerrebroeck, Philip